Congenica
OverviewSuggest Edit
Congenica is a UK start-up company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories. We are translating this research into a revolutionary clinical genomic analytics platform, Sapientia, for processing genome-wide data sets of human DNA sequence with deep clinical phenotype information in order to provide a definitive molecular diagnosis and clinically actionable interpretation for treatment, patient stratification and improved therapeutic discoveries.
| Type | Private | |
| Founded | 2014 | |
| Website | congenica.com |
Recent NewsAll News
Latest Updates
| Employees (est.) (Dec 2019) | 74 | (+2%) |
Key People/Management at Congenica
David Atkins
Nick Lench
Andy Richards
Matthew Hurles
David Shi
Michael Anstey
Congenica Office Locations
Congenica Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Congenica total Funding | $32.2 m |
Congenica latest funding size | $17.45 m |
Time since last funding | 9 months ago |
Congenica investors | Amadeus Capital Partners, Parkwalk Advisors Ltd, Cambridge Innovation Capital, Future Planet Capital, Parkwalk Advisors, Digital China Health Technologies Corporation (DCHealth) |
Congenica Online and Social Media Presence
1.68k Twitter followers
Congenica has 1.68k Twitter Followers. The number of followers has increased 2.2% month over month and increased 4.2% quarter over quarter
Congenica's Trends
Twitter Engagement Stats for @Congenica
1.9k
Tweets
539
Following
1.7k
Followers
6
Tweets last 30 days
2.8
Avg. likes per Tweet
100%
Tweets with engagement
Congenica News and Updates
Congenica makes Atkins its CEO
Congenica Blogs
Congenica launches new application to enable faster analysis of epilepsy and neurodevelopmental disorders
Download Congenica Neuro Datasheet
Re-annotation of Developmental and Epileptic Encephalopathy-associated genes unmasks de novo variants
Re-annotation of 191 developmental and epileptic encephalopathy-associated genes unmasks de novo variants in SCN1A
Maximizing NGS lab efficiency in the analysis and interpretation of genomic data
A fast and reliable method to reach a conclusive diagnosis of MYH9-related disorder
Congenica Frequently Asked Questions
When was Congenica founded?
Congenica was founded in 2014.
Who are Congenica key executives?
Congenica's key executives are David Atkins, Nick Lench and Andy Richards.
How many employees does Congenica have?
Congenica has 74 employees.
Who are Congenica competitors?
Competitors of Congenica include Gemini Therapeutics, Senti Biosciences and Phosphorus.
Where are Congenica offices?
Congenica has an office in Hinxton.
How many offices does Congenica have?
Congenica has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies